New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists

Overview publication

TitleNew-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists
DateJuly 1st, 2020
Issue nameMinerva Endocrinologica
Issue numberv45.2
DOI10.23736/s0391-1977.20.03179-x
AuthorsBarrea L, Pugliese G, Muscogiuri G, Laudisio D, Colao A & Savastano S
Read Read publication